ALPHARETTA, Ga., May 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Sigfrido (Sig) Delgado has been appointed senior vice president, integrated supply chain. In this role, Delgado will lead the teams focused on implementing continuous improvements within the Company's end-to-end supply chain capabilities worldwide. Delgado joins Avanos from Jabil Healthcare, the industry's largest global provider of healthcare manufacturing solutions, where he most recently served as vice pr ...

Avanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Conference Call May 2, 2024 9:00 AM ET Company Participants Scott Galovan - Senior Vice President, Strategy & Corporate Development Joe Woody - Chief Executive Officer Michael Greiner - Senior Vice President, Chief Financial Officer & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Daniel Stauder - JMP Securities Operator Good morning ladies and gentlemen and welcome to the Avanos First Quarter 2024 Earnings Conference. At ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36440 AVANOS MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 46-4987888 (State o ...

Avanos Medical (AVNS) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.27 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -9.52%. A quarter ago, it was expected that this medical technology company would post earnings of $0.37 per share when it actually produced earnings of $0.36, delivering a surprise of -2.70%.Over the last four quar ...

AVANOS Investor Contact: Michael Greiner Avanos Medical, Inc. 470-562-2692 Investor.Relations@Avanos.com Media Contact: Katrine Kubis Avanos Medical, Inc. CorporateCommunications@Avanos.com Avanos Medical, Inc. Announces First Quarter 2024 Results ALPHARETTA, Ga., May 2, 2024/PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2024 financial results. "As we begin the second year of our three-year transformation initiative, we are pleased with our first quarter results," said Joe Wo ...

ALPHARETTA, Ga., April 25, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer.To join t ...

Avanos Medical, Inc. (AVNS) is well-poised for growth in the coming quarters, courtesy of its impressive product line. The optimism led by a solid fourth-quarter 2023 performance and continued focus on its research and development (R&D) are expected to contribute further. However, stiff competition and macroeconomic concerns persist.Over the past year, this Zacks Rank #3 (Hold) stock has lost 33.9% against the 9.8% rise of the industry and 27.6% growth of the S&P 500 Composite.The renowned medical device so ...

ALPHARETTA, Ga., Feb. 21, 2024 /PRNewswire/ -- In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024. These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of the feeding tube. The Nurse Assist voluntary recall was initiated due to concerns abo ...

Avanos Medical, Inc. (AVNS) reported fourth-quarter 2023 adjusted earnings per share (EPS) from continuing operations of 36 cents, down 20% year over year. The bottom line missed the Zacks Consensus Estimate by a penny.GAAP EPS from continuing operations in the quarter under review was 24 cents, up 14.3% year over year.Full-year adjusted EPS was $1.03, up 3% compared with that at the end of the comparable 2022 period. The figure lagged the Zacks Consensus Estimate by 0.9%.RevenuesRevenues grossed $173.3 mil ...

Avanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Conference Call February 20, 2024 9:00 AM ET Company Participants Scott Galovan - Senior Vice President, Strategy & Corporate Development Joe Woody - Chief Executive Officer Michael Greiner - Senior Vice President, Chief Financial Officer & Chief Transformation Officer Conference Call Participants Daniel Stauder - JMP Securities Rick Wise - Stifel Kristen Stewart - CL King Operator Good day and welcome to the Avanos Fourth Quarter and Full Year 2023 Earnings ...